you are here: Home News Zydus Cadila

Zydus Cadila

COVID-19 | India to soon roll out world's first DNA vaccine. Price, efficacy and all you need to know
Zydus Cadila gets USFDA nod for generic drug
ZyCov-D vaccine to be initially supplied to 7 states including Maharashtra, Bengal: Report
Zydus Cadila gets USFDA nod to market generic cancer drug in US
Zydus Cadila gets USFDA nod for cancer drug with 180-days exclusivity
Zydus Cadila's COVID vaccine to be administered only to adults as of now: Report
ZyCov-D: Zydus Cadila's 3-dose needle-free COVID-19 vaccine to cost Rs 1,128
Zydus Cadila agrees to reduce its COVID-19 vaccine price to Rs 265 a dose, final decision soon: Sources
Zydus Cadila gets nod for phase 3 trial of two-dose regimen of ZyCoV-D
Zydus Cadila unit gets USFDA nod for generic plaque psoriasis treatment drug
Zydus Cadila gets USFDA nod for schizophrenia treatment drug
Zydus Cadila gets USFDA nod for diabetes medication
ZyCoV-D, the needle-less DNA vaccine: how is it different from Covishield & Covaxin
Zydus Cadila will seek nod for ZyCoV-D trial on 3-12 age group within 10 days: MD Sharvil Patel
Zydus Cadila's needle-free 3-dose COVID-19 vaccine cleared for emergency use: Report
Zydus Cadila COVID-19 vaccine to get emergency use approval this week: Report
Zydus Cadila gets USFDA nod for breast cancer treatment drug
Zydus Cadila COVID-19 vaccine: Decision on emergency use approval likely this week
Zydus Cadila’s Sharvil Patel: We will manufacture one crore doses per month initially
Zydus Cadila gets USFDA nod to market generic HIV infection treatment tablets
Needle-free, three doses—here’s all you need to know about Zydus Cadila’s COVID jab
Zydus Cadila's COVID-19 vaccine will be available for 12-18 age group soon, Centre tells SC
Zydus Cadila gets USFDA approval for generic cancer drug
Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug
Zydus gets SEC nod to conduct clinical trial of COVID-19 antibody cocktail

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Zydus Cadila

COVID-19 | India to soon roll out world's first DNA vaccine. Price, efficacy and all you need to know

Zydus Cadila gets USFDA nod for generic drug

ZyCov-D vaccine to be initially supplied to 7 states including Maharashtra, Bengal: Report

Zydus Cadila gets USFDA nod to market generic cancer drug in US

Zydus Cadila gets USFDA nod for cancer drug with 180-days exclusivity

Zydus Cadila's COVID vaccine to be administered only to adults as of now: Report

ZyCov-D: Zydus Cadila's 3-dose needle-free COVID-19 vaccine to cost Rs 1,128

Zydus Cadila agrees to reduce its COVID-19 vaccine price to Rs 265 a dose, final decision soon: Sources

Zydus Cadila gets nod for phase 3 trial of two-dose regimen of ZyCoV-D

Zydus Cadila unit gets USFDA nod for generic plaque psoriasis treatment drug

Zydus Cadila gets USFDA nod for schizophrenia treatment drug

Zydus Cadila gets USFDA nod for diabetes medication

ZyCoV-D, the needle-less DNA vaccine: how is it different from Covishield & Covaxin

Zydus Cadila will seek nod for ZyCoV-D trial on 3-12 age group within 10 days: MD Sharvil Patel

Zydus Cadila's needle-free 3-dose COVID-19 vaccine cleared for emergency use: Report

Zydus Cadila COVID-19 vaccine to get emergency use approval this week: Report

Zydus Cadila gets USFDA nod for breast cancer treatment drug

Zydus Cadila COVID-19 vaccine: Decision on emergency use approval likely this week

Zydus Cadila’s Sharvil Patel: We will manufacture one crore doses per month initially

Zydus Cadila gets USFDA nod to market generic HIV infection treatment tablets

Needle-free, three doses—here’s all you need to know about Zydus Cadila’s COVID jab

Zydus Cadila's COVID-19 vaccine will be available for 12-18 age group soon, Centre tells SC

Zydus Cadila gets USFDA approval for generic cancer drug

Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug

Zydus gets SEC nod to conduct clinical trial of COVID-19 antibody cocktail